Skip to main content
Erschienen in: Reviews in Endocrine and Metabolic Disorders 2/2019

07.05.2019

Prader- Willi syndrome: An uptodate on endocrine and metabolic complications

verfasst von: Giovanna Muscogiuri, Gloria Formoso, Gabriella Pugliese, Rosaria Maddalena Ruggeri, Elisabetta Scarano, Annamaria Colao, on behalf of RESTARE

Erschienen in: Reviews in Endocrine and Metabolic Disorders | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Prader-Willi syndrome (PWS) is a genetic disorder characterized by short stature, low lean body mass, muscular hypotonia, mental retardation, behavioral abnormalities, dysmorphic features, and excessive appetite with progressive obesity. It is caused by lack of expression of genes on the paternally inherited chromosome 15q11.2-q13. This genetic disorder has an estimated prevalence that ranges between 1/10,000–1/30,000. Hypothalamic dysfunction is a common finding in PWS and it has been implicated in several manifestations of this syndrome such as hyperphagia, temperature instability, high pain threshold, sleep disordered breathing, and multiple endocrine abnormalities. These include growth hormone deficiency, central adrenal insufficiency, hypogonadism, hypothyroidism, and obesity often complicated by type 2 diabetes. The aim of this manuscript is to overview the current literature on metabolic and endocrine complications of PWS, focusing on human studies and providing insights on the physio pathological mechanisms. A careful management of metabolic and endocrine complications can contribute to improve quality of life, prevent complications, and prolong life expectancy of PW patients.
Literatur
1.
Zurück zum Zitat Kanaka-Gantenbein C, Kogia C, Abdel-Naser MB, Chrousos GP. Skin manifestations of growth hormone-induced diseases. Rev Endocr Metab Disord. 2016;17(3):259–67.CrossRefPubMed Kanaka-Gantenbein C, Kogia C, Abdel-Naser MB, Chrousos GP. Skin manifestations of growth hormone-induced diseases. Rev Endocr Metab Disord. 2016;17(3):259–67.CrossRefPubMed
5.
Zurück zum Zitat Fitch A. Effective dietary therapies for pediatric obesity treatment. Rev Endocr Metab Disord. 2009;10(3):231–6.CrossRefPubMed Fitch A. Effective dietary therapies for pediatric obesity treatment. Rev Endocr Metab Disord. 2009;10(3):231–6.CrossRefPubMed
6.
Zurück zum Zitat Butler JV, Whittington JE, Holland AJ, Boer H, Clarke D, Webb T. Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study. Dev Med Child Neurol. 2002;44(4):248–55.CrossRefPubMed Butler JV, Whittington JE, Holland AJ, Boer H, Clarke D, Webb T. Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study. Dev Med Child Neurol. 2002;44(4):248–55.CrossRefPubMed
7.
Zurück zum Zitat Lind van Wijngaarden RF, Otten BJ, Festen DA, Joosten KF, de Jong FH, Sweep FC, et al. High prevalence of central adrenal insufficiency in patients with PraderWilli syndrome. J Clin Endocrinol Metab. 2008;93:1649–54.CrossRefPubMed Lind van Wijngaarden RF, Otten BJ, Festen DA, Joosten KF, de Jong FH, Sweep FC, et al. High prevalence of central adrenal insufficiency in patients with PraderWilli syndrome. J Clin Endocrinol Metab. 2008;93:1649–54.CrossRefPubMed
8.
Zurück zum Zitat Tauber M, Barbeau C, Jouret B, Pienkowski C, Malzac P, Moncla A, et al. Auxological and endocrine evolution of 28 children with Prader-Willi syndrome: effect of GH therapy in 14 children. Horm Res. 2000;53(6):279–87.PubMed Tauber M, Barbeau C, Jouret B, Pienkowski C, Malzac P, Moncla A, et al. Auxological and endocrine evolution of 28 children with Prader-Willi syndrome: effect of GH therapy in 14 children. Horm Res. 2000;53(6):279–87.PubMed
9.
Zurück zum Zitat Angulo MA, Castro-Magana M, Lamerson M, Arguello R, Accacha S, Khan A. Final adult height in children with Prader-Willi syndrome with and without human growth hormone treatment. Am J Med Genet A. 2007;143A(13):1456–61.CrossRefPubMed Angulo MA, Castro-Magana M, Lamerson M, Arguello R, Accacha S, Khan A. Final adult height in children with Prader-Willi syndrome with and without human growth hormone treatment. Am J Med Genet A. 2007;143A(13):1456–61.CrossRefPubMed
10.
Zurück zum Zitat Zhang Y, Wang J, Zhang G, et al. The neurobiological drive for overeating implicated in Prader–Willi syndrome. Brain Res. 2015;1620:72–80.CrossRefPubMed Zhang Y, Wang J, Zhang G, et al. The neurobiological drive for overeating implicated in Prader–Willi syndrome. Brain Res. 2015;1620:72–80.CrossRefPubMed
11.
Zurück zum Zitat Butler MG, Theodoro MF, Bittel DC, Donnelly JE. Energy expenditure and physical activity in Prader–Willi syndrome: comparison with obese subjects. Am J Med Genet A. 2007;143A:449–59.CrossRefPubMedPubMedCentral Butler MG, Theodoro MF, Bittel DC, Donnelly JE. Energy expenditure and physical activity in Prader–Willi syndrome: comparison with obese subjects. Am J Med Genet A. 2007;143A:449–59.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Burman P, Ritzen EM, Lindgren AC. Endocrine dysfunction in Prader–Willi syndrome: a review with special reference to GH. Endocr Rev. 2001;22:787–799.2.CrossRefPubMed Burman P, Ritzen EM, Lindgren AC. Endocrine dysfunction in Prader–Willi syndrome: a review with special reference to GH. Endocr Rev. 2001;22:787–799.2.CrossRefPubMed
13.
Zurück zum Zitat Dimitropoulos A, Schultz RT. Food-related neural circuitry in Prader- Willi syndrome: response to high- versus low-calorie foods. J Autism Dev Disord. 2008;38(9):1642–53.CrossRefPubMed Dimitropoulos A, Schultz RT. Food-related neural circuitry in Prader- Willi syndrome: response to high- versus low-calorie foods. J Autism Dev Disord. 2008;38(9):1642–53.CrossRefPubMed
14.
Zurück zum Zitat Pujol J, Blanco-Hinojo L, Esteba-Castillo S, Caixàs A, Harrison BJ, Bueno M, et al. Anomalous basal ganglia connectivity and obsessive-compulsive behaviour in patients with Prader-Willi syndrome. J Psychiatry Neurosci. 2016;41(4):261–71.CrossRefPubMed Pujol J, Blanco-Hinojo L, Esteba-Castillo S, Caixàs A, Harrison BJ, Bueno M, et al. Anomalous basal ganglia connectivity and obsessive-compulsive behaviour in patients with Prader-Willi syndrome. J Psychiatry Neurosci. 2016;41(4):261–71.CrossRefPubMed
15.
Zurück zum Zitat Miller JL, Lynn CH, Driscoll DC, Goldstone AP, Gold JA, Kimonis V, et al. Nutritional phases in Prader Willi syndrome. Am J Med Genet A. 2011;155(5):1040–9.CrossRef Miller JL, Lynn CH, Driscoll DC, Goldstone AP, Gold JA, Kimonis V, et al. Nutritional phases in Prader Willi syndrome. Am J Med Genet A. 2011;155(5):1040–9.CrossRef
16.
Zurück zum Zitat Goldstone AP, Holland AJ, Butler JV, Whittington JE. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome. Int J Obes. 2012;36(12):1564–70.CrossRef Goldstone AP, Holland AJ, Butler JV, Whittington JE. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome. Int J Obes. 2012;36(12):1564–70.CrossRef
17.
Zurück zum Zitat Butler MG, Moore J, Morawiecki A, Nicolson M. Comparison of leptin protein levels in Prader-Willi syndrome and control individuals. Am J Med Genet. 1998;75(1):7–12.CrossRefPubMedPubMedCentral Butler MG, Moore J, Morawiecki A, Nicolson M. Comparison of leptin protein levels in Prader-Willi syndrome and control individuals. Am J Med Genet. 1998;75(1):7–12.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Lim CT, Kola B, Korbonits M. The ghrelin/GOAT/GHS-R system and energy metabolism. Rev Endocr Metab Disord. 2011;12(3):173–86.CrossRefPubMed Lim CT, Kola B, Korbonits M. The ghrelin/GOAT/GHS-R system and energy metabolism. Rev Endocr Metab Disord. 2011;12(3):173–86.CrossRefPubMed
19.
Zurück zum Zitat Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001;86(12):5992.CrossRefPubMed Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001;86(12):5992.CrossRefPubMed
20.
Zurück zum Zitat Irizarry KA, Miller M, Freemark M, Haqq AM. Prader Willi syndrome: genetics, metabolomics, hormonal function, and new approaches to therapy. Adv Pediatr. 2016;63:47–77.CrossRefPubMedPubMedCentral Irizarry KA, Miller M, Freemark M, Haqq AM. Prader Willi syndrome: genetics, metabolomics, hormonal function, and new approaches to therapy. Adv Pediatr. 2016;63:47–77.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Bekx MT, Carrel AL, Shriver TC, Li Z, Allen DB. Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi syndrome. J Pediatr. 2003;143(3):372–6.CrossRefPubMed Bekx MT, Carrel AL, Shriver TC, Li Z, Allen DB. Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi syndrome. J Pediatr. 2003;143(3):372–6.CrossRefPubMed
22.
Zurück zum Zitat Purtell L, Viardot A, Sze L, Loughnan G, Steinbeck K, Sainsbury A, et al. Postprandial metabolism in adults with Prader-Willi syndrome. Obesity (Silver Spring). 2015;23(6):1159–65.CrossRef Purtell L, Viardot A, Sze L, Loughnan G, Steinbeck K, Sainsbury A, et al. Postprandial metabolism in adults with Prader-Willi syndrome. Obesity (Silver Spring). 2015;23(6):1159–65.CrossRef
23.
Zurück zum Zitat Brambilla P, Crinò A, Bedogni G, Genetic Obesity Study Group of the Italian Society of Pediatric Endocrinology and Diabetology (ISPED), et al. Metabolic syndrome in children with Prader-Willi syndrome: the effect of obesity. Nutr Metab Cardiovasc Dis. 2011;21(4):269–76.PubMed Brambilla P, Crinò A, Bedogni G, Genetic Obesity Study Group of the Italian Society of Pediatric Endocrinology and Diabetology (ISPED), et al. Metabolic syndrome in children with Prader-Willi syndrome: the effect of obesity. Nutr Metab Cardiovasc Dis. 2011;21(4):269–76.PubMed
24.
Zurück zum Zitat Goldstone AP, Thomas EL, Brynes AE, et al. Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution. J Clin Endocrinol Metab. 2001;86(9):4330–8.CrossRefPubMed Goldstone AP, Thomas EL, Brynes AE, et al. Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution. J Clin Endocrinol Metab. 2001;86(9):4330–8.CrossRefPubMed
25.
Zurück zum Zitat Schuster DP, Osei K, Zipf WB. Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects. Metabolism. 1996;45(12):1514–20.CrossRefPubMed Schuster DP, Osei K, Zipf WB. Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects. Metabolism. 1996;45(12):1514–20.CrossRefPubMed
26.
Zurück zum Zitat Talebizadeh Z, Butler MG. Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects. Clin Genet. 2004;67(3):230–9.CrossRef Talebizadeh Z, Butler MG. Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects. Clin Genet. 2004;67(3):230–9.CrossRef
27.
Zurück zum Zitat Fintini D, Grugni G, Brufani C, Bocchini S, Cappa M, Crino A. Use of GLP-1 receptor agonists in Prader-Willi syndrome: report of six cases. Diabetes Care. 2014;37:e76–7.CrossRefPubMed Fintini D, Grugni G, Brufani C, Bocchini S, Cappa M, Crino A. Use of GLP-1 receptor agonists in Prader-Willi syndrome: report of six cases. Diabetes Care. 2014;37:e76–7.CrossRefPubMed
28.
Zurück zum Zitat Berthoud HR, Powley TL. Morphology and distribution of efferent vagal innervation of rat pancreas as revealed with anterograde transport of Dil. Brain Res. 1991;553:336–41.CrossRefPubMed Berthoud HR, Powley TL. Morphology and distribution of efferent vagal innervation of rat pancreas as revealed with anterograde transport of Dil. Brain Res. 1991;553:336–41.CrossRefPubMed
29.
Zurück zum Zitat Fitch A, Bock J. Effective dietary therapies for pediatric obesity treatment. Rev Endocr Metab Disord. 2009;10(3):231–6.CrossRefPubMed Fitch A, Bock J. Effective dietary therapies for pediatric obesity treatment. Rev Endocr Metab Disord. 2009;10(3):231–6.CrossRefPubMed
30.
Zurück zum Zitat Sze L, Purtell L, Jenkins A, Loughnan G, Smith E, Herzog H, et al. Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome. J Clin Endocrionl Metab. 2011;96:E1314–9.CrossRef Sze L, Purtell L, Jenkins A, Loughnan G, Smith E, Herzog H, et al. Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome. J Clin Endocrionl Metab. 2011;96:E1314–9.CrossRef
32.
Zurück zum Zitat Sharkia M, Michaud S, Berthier MT. Thyroid function from birth to adolescence in Prader-Willi syndrome. J Pediatr. 2013;163:800–5.CrossRefPubMed Sharkia M, Michaud S, Berthier MT. Thyroid function from birth to adolescence in Prader-Willi syndrome. J Pediatr. 2013;163:800–5.CrossRefPubMed
33.
Zurück zum Zitat Diene G, Mimoun E, Feigerlova E, Caula S, Molinas C, Grandjean H. Endocrine disorders in children with Prader-Willi syndrome – data from 142 children of the French database. Horm Res Paediatr. 2010;74:121–8.CrossRefPubMed Diene G, Mimoun E, Feigerlova E, Caula S, Molinas C, Grandjean H. Endocrine disorders in children with Prader-Willi syndrome – data from 142 children of the French database. Horm Res Paediatr. 2010;74:121–8.CrossRefPubMed
34.
Zurück zum Zitat Vaiani E, Herzovich V, Chaler E, Chertkoff L, Rivarola M, Torrado M, et al. Thyroid axis dysfunction in patients with Prader-Willi syndrome during the first 2 years of life. Clin Endocrinol. 2010;73:546–50. Vaiani E, Herzovich V, Chaler E, Chertkoff L, Rivarola M, Torrado M, et al. Thyroid axis dysfunction in patients with Prader-Willi syndrome during the first 2 years of life. Clin Endocrinol. 2010;73:546–50.
35.
Zurück zum Zitat Goldstone AP, Holland AJ, Hauffa BP, Hokken-Koelega AC, Tauber M. Recommendations for the diagnosis and management of Prader-Willi Syndrome. J Clin Endocrinol Metab. 2008;93(11):4183–97.CrossRefPubMed Goldstone AP, Holland AJ, Hauffa BP, Hokken-Koelega AC, Tauber M. Recommendations for the diagnosis and management of Prader-Willi Syndrome. J Clin Endocrinol Metab. 2008;93(11):4183–97.CrossRefPubMed
36.
Zurück zum Zitat Festen D, Visser T, Otten B, Wit J. Thyroid hormone levels in children with Prader–Willi syndrome before and during growth hormone treatment. Clin Endocrinol. 2007;67:449–56.CrossRef Festen D, Visser T, Otten B, Wit J. Thyroid hormone levels in children with Prader–Willi syndrome before and during growth hormone treatment. Clin Endocrinol. 2007;67:449–56.CrossRef
37.
Zurück zum Zitat Bocchini S, Fintini D, Grugni G, Boiani A, Convertino A, Crinò A. Congenital hypothyroidism due to ectopic sublingual thyroid gland in Prader-Willi syndrome: a case report. Ital J Pediatr. 2017;43:87.CrossRefPubMedPubMedCentral Bocchini S, Fintini D, Grugni G, Boiani A, Convertino A, Crinò A. Congenital hypothyroidism due to ectopic sublingual thyroid gland in Prader-Willi syndrome: a case report. Ital J Pediatr. 2017;43:87.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Sher C, Bistritzer T, Reisler G, Reish O. Congenital hypothyroidism with Prader-Willi syndrome. J Pediatr Endocrinol Metab. 2002;15:105–7.CrossRefPubMed Sher C, Bistritzer T, Reisler G, Reish O. Congenital hypothyroidism with Prader-Willi syndrome. J Pediatr Endocrinol Metab. 2002;15:105–7.CrossRefPubMed
39.
Zurück zum Zitat Insoft RM, Hurvitz J, Estrella E, Krishnamoorthy KS. Prader-Willi syndrome associated with fetal goiter: a case report. Am J Perinatol. 1999;16:29–31 14.CrossRefPubMed Insoft RM, Hurvitz J, Estrella E, Krishnamoorthy KS. Prader-Willi syndrome associated with fetal goiter: a case report. Am J Perinatol. 1999;16:29–31 14.CrossRefPubMed
40.
Zurück zum Zitat Whittington JE, Holland AJ, Webb T, Butler J, Clarke D, Boer H. Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. J Med Genet. 2001;38:792–8.CrossRefPubMedPubMedCentral Whittington JE, Holland AJ, Webb T, Butler J, Clarke D, Boer H. Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. J Med Genet. 2001;38:792–8.CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Stevenson DA, Anaya TM, Clayton-Smith J, Hall BD, van Allen MI, Zori RT, et al. Unexpected death and critical illness in Prader-Willi syndrome: Report of ten individuals. Am J Med Genet A. 2004;124:158–64.CrossRef Stevenson DA, Anaya TM, Clayton-Smith J, Hall BD, van Allen MI, Zori RT, et al. Unexpected death and critical illness in Prader-Willi syndrome: Report of ten individuals. Am J Med Genet A. 2004;124:158–64.CrossRef
42.
Zurück zum Zitat Corrias A, Grugni G. Assessment of central adrenal insufficiency in children and adolescents with Prader-Willi syndrome. Clin Endocrinol. 2012;76:843–50.CrossRef Corrias A, Grugni G. Assessment of central adrenal insufficiency in children and adolescents with Prader-Willi syndrome. Clin Endocrinol. 2012;76:843–50.CrossRef
43.
Zurück zum Zitat Grugni G, Beccaria L, Corias A, Crino A, Cappa M, de Medici C, et al. Central adrenal insufficiency in young adults with Prader-Willi syndrome. Clin Endocrinol. 2013;79:371–8.CrossRef Grugni G, Beccaria L, Corias A, Crino A, Cappa M, de Medici C, et al. Central adrenal insufficiency in young adults with Prader-Willi syndrome. Clin Endocrinol. 2013;79:371–8.CrossRef
44.
Zurück zum Zitat Beauloye V, Dhondt K, Buysse W, Nyakasane A. Evaluation of the hypothalamic-pituitaryadrenal axis and its relationship with central respiratory dysfunction in children with Prader-Willi syndrome. Orphanet J Rare Diss. 2015;10:106.CrossRef Beauloye V, Dhondt K, Buysse W, Nyakasane A. Evaluation of the hypothalamic-pituitaryadrenal axis and its relationship with central respiratory dysfunction in children with Prader-Willi syndrome. Orphanet J Rare Diss. 2015;10:106.CrossRef
45.
Zurück zum Zitat Connell, Paterson WF, Wallace AM, Donaldson MDC. Adrenal function and mortality in children and adolescents with Prader–Willi syndrome attending a single centre from 1991–2009. Clin Endocrinol. 2010;73:686–8.CrossRef Connell, Paterson WF, Wallace AM, Donaldson MDC. Adrenal function and mortality in children and adolescents with Prader–Willi syndrome attending a single centre from 1991–2009. Clin Endocrinol. 2010;73:686–8.CrossRef
46.
Zurück zum Zitat Nyunt O, Cotterill AM, Archbold SM, Wu JY, Leong GM, Verge CF, et al. Normal cortisol response on low-dose synacthen (1 microg) test in children with Prader Willi syndrome. J Clin Endocrinol Metab. 2010;95:E464–7.CrossRefPubMed Nyunt O, Cotterill AM, Archbold SM, Wu JY, Leong GM, Verge CF, et al. Normal cortisol response on low-dose synacthen (1 microg) test in children with Prader Willi syndrome. J Clin Endocrinol Metab. 2010;95:E464–7.CrossRefPubMed
47.
Zurück zum Zitat Farholt S, Sode-Carlsen R, Christiansen JS, Ostergaard JR, Hoybye C. Normal cortisol response to high dose synacthen and insulin tolerance test in children and adults with Prader-Willi syndrome. J Clin Endocrinol Metab. 2011;96:E173–80.CrossRefPubMed Farholt S, Sode-Carlsen R, Christiansen JS, Ostergaard JR, Hoybye C. Normal cortisol response to high dose synacthen and insulin tolerance test in children and adults with Prader-Willi syndrome. J Clin Endocrinol Metab. 2011;96:E173–80.CrossRefPubMed
48.
Zurück zum Zitat de Lind van Wijngaarden RFA, Joosten KFM, van den Berg S, Otten BJ. The relationship between central adrenal insufficiency and sleep-related breathing disorders in children with Prader-Willi syndrome. J Clin Endocrinol Metabol. 2009;94(7):2387–93.CrossRef de Lind van Wijngaarden RFA, Joosten KFM, van den Berg S, Otten BJ. The relationship between central adrenal insufficiency and sleep-related breathing disorders in children with Prader-Willi syndrome. J Clin Endocrinol Metabol. 2009;94(7):2387–93.CrossRef
49.
Zurück zum Zitat Barbara DW, Hannon JD, Hartman WR. Intraoperative adrenal insufficiency in patients with Prader-Willi syndrome. J Clin Endocrinol Metab. 2008;93:1649–54.CrossRef Barbara DW, Hannon JD, Hartman WR. Intraoperative adrenal insufficiency in patients with Prader-Willi syndrome. J Clin Endocrinol Metab. 2008;93:1649–54.CrossRef
52.
Zurück zum Zitat Vogels A, Moerman P, Frijns JP, Bogaert GA. Testicular histology in boys with Prader-Willi syndrome: fertile or infertile? J Urol. 2008;180(1800–1804):113. Vogels A, Moerman P, Frijns JP, Bogaert GA. Testicular histology in boys with Prader-Willi syndrome: fertile or infertile? J Urol. 2008;180(1800–1804):113.
53.
Zurück zum Zitat Siemensma EP, de Lind van Wijngaarden RF, Otten BJ, de Jong FH, Hokken-Koelega AC. Testicular failure in boys with Prader-Willi syndrome: longitudinal studies of reproductive hormones. J Clin Endocrinol Metab. 2012;97:E452–9 114.CrossRefPubMed Siemensma EP, de Lind van Wijngaarden RF, Otten BJ, de Jong FH, Hokken-Koelega AC. Testicular failure in boys with Prader-Willi syndrome: longitudinal studies of reproductive hormones. J Clin Endocrinol Metab. 2012;97:E452–9 114.CrossRefPubMed
54.
Zurück zum Zitat Eldar-Geva T, Hirsch HJ, Rabinowitz R, Benarroch F, Rubinstein O, Gross-Tsur V. Primary ovarian dysfunction contributes to the hypogonadism in women with Prader-Willi syndrome. Horm Res. 2009;72(3):153–9 120.CrossRefPubMed Eldar-Geva T, Hirsch HJ, Rabinowitz R, Benarroch F, Rubinstein O, Gross-Tsur V. Primary ovarian dysfunction contributes to the hypogonadism in women with Prader-Willi syndrome. Horm Res. 2009;72(3):153–9 120.CrossRefPubMed
55.
Zurück zum Zitat Eldar-Geva T, Hirsch HJ, Benarroch F, Rubinstein O, GrossTsur V. Hypogonadism in females with Prader-Willi syndrome from infancy to adulthood: variable combinations of a primary gonadal defect and hypothalamic dysfunction. Eur J Endocrinol. 2010;162(2):377–84 121.CrossRefPubMed Eldar-Geva T, Hirsch HJ, Benarroch F, Rubinstein O, GrossTsur V. Hypogonadism in females with Prader-Willi syndrome from infancy to adulthood: variable combinations of a primary gonadal defect and hypothalamic dysfunction. Eur J Endocrinol. 2010;162(2):377–84 121.CrossRefPubMed
56.
Zurück zum Zitat Radicioni AF, Di Giorgio G, Grugni G, Cuttini M, Losacco V, Anzuini A, et al. Multiple forms of hypogonadism of central, peripheral or combined origin in males with Prader-Willi syndrome. Clin Endocrinol (Oxf). 2012;76:72–7 115.CrossRef Radicioni AF, Di Giorgio G, Grugni G, Cuttini M, Losacco V, Anzuini A, et al. Multiple forms of hypogonadism of central, peripheral or combined origin in males with Prader-Willi syndrome. Clin Endocrinol (Oxf). 2012;76:72–7 115.CrossRef
57.
Zurück zum Zitat Eiholzer U, l’Allemand D, Rousson V, Schlumpf M, Gasser T, Girard J, et al. Hypothalamic and gonadal components of hypogonadism in boys with Prader-Labhart-Willi syndrome. J Clin Endocrinol Metab. 2006;91:892–8.CrossRefPubMed Eiholzer U, l’Allemand D, Rousson V, Schlumpf M, Gasser T, Girard J, et al. Hypothalamic and gonadal components of hypogonadism in boys with Prader-Labhart-Willi syndrome. J Clin Endocrinol Metab. 2006;91:892–8.CrossRefPubMed
58.
Zurück zum Zitat Crinò A, Schiaffini R, Ciampalini P, Spera S, Beccaria L, Benzi F, et al. Genetic obesity study Group of Italian Society of pediatric endocrinology and diabetology (SIEDP). Hypogonadism and pubertal development in Prader-Willi syndrome. Eur J Pediatr. 2003;162(5):327–33.PubMed Crinò A, Schiaffini R, Ciampalini P, Spera S, Beccaria L, Benzi F, et al. Genetic obesity study Group of Italian Society of pediatric endocrinology and diabetology (SIEDP). Hypogonadism and pubertal development in Prader-Willi syndrome. Eur J Pediatr. 2003;162(5):327–33.PubMed
59.
Zurück zum Zitat Bakker NE, Wolffenbuttel KP, Looijenga LH, Hokken-Koelega AC. Testes in infants with Prader-Willi syndrome: human chorionic gonadotropin treatment, surgery and histology. J Urol. 2015;193(1):291–8.CrossRefPubMed Bakker NE, Wolffenbuttel KP, Looijenga LH, Hokken-Koelega AC. Testes in infants with Prader-Willi syndrome: human chorionic gonadotropin treatment, surgery and histology. J Urol. 2015;193(1):291–8.CrossRefPubMed
60.
Zurück zum Zitat Fillion M, Deal CL, Van Vliet G. Normal minipuberty of infancy in boys with Prader-Willi syndrome. J Pediatr. 2006;149(874–876):117. Fillion M, Deal CL, Van Vliet G. Normal minipuberty of infancy in boys with Prader-Willi syndrome. J Pediatr. 2006;149(874–876):117.
61.
Zurück zum Zitat Hirsch HJ, Eldar-Geva T, Benarroch F, Rubinstein O, Gross-Tsur V. Primary testicular dysfunction is a major contributor to abnormal pubertal development in males with Prader-Willi syndrome. J Clin Endocrinol Metab. 2009;94(7):2262–8.CrossRefPubMed Hirsch HJ, Eldar-Geva T, Benarroch F, Rubinstein O, Gross-Tsur V. Primary testicular dysfunction is a major contributor to abnormal pubertal development in males with Prader-Willi syndrome. J Clin Endocrinol Metab. 2009;94(7):2262–8.CrossRefPubMed
62.
Zurück zum Zitat Hirsch HJ, Eldar-Geva T, Erlichman M, Pollak Y, Gross-Tsur V. Characterization of minipuberty in infants with PraderWilli syndrome. Horm Res Paediatr. 2014;82(230–237):118. Hirsch HJ, Eldar-Geva T, Erlichman M, Pollak Y, Gross-Tsur V. Characterization of minipuberty in infants with PraderWilli syndrome. Horm Res Paediatr. 2014;82(230–237):118.
63.
Zurück zum Zitat Brandau DT, Theodoro M, Garg U, Butler MG. Follicle stimulating and leutinizing hormones, estradiol and testosterone in Prader-Willi syndrome. Am J Med Genet A. 2008;146A(5):665–9.CrossRefPubMedPubMedCentral Brandau DT, Theodoro M, Garg U, Butler MG. Follicle stimulating and leutinizing hormones, estradiol and testosterone in Prader-Willi syndrome. Am J Med Genet A. 2008;146A(5):665–9.CrossRefPubMedPubMedCentral
64.
Zurück zum Zitat Hirsch HJ, Eldar-Geva T, Bennaroch F, Pollak Y, Gross-Tsur V. Sexual dichotomy of gonadal function in Prader-Willi syndrome from early infancy through the fourth decade. Hum Reprod. 2015;30(11):2587–96.CrossRefPubMed Hirsch HJ, Eldar-Geva T, Bennaroch F, Pollak Y, Gross-Tsur V. Sexual dichotomy of gonadal function in Prader-Willi syndrome from early infancy through the fourth decade. Hum Reprod. 2015;30(11):2587–96.CrossRefPubMed
66.
Zurück zum Zitat Hirsch HJ, Eldar-Geva T, Erlichman M, Pollak Y, Gross-Tsur V. Characterization of minipuberty in infants with Prader Willi syndrome. Horm Res Paediatr. 2014;82(230–237):118. Hirsch HJ, Eldar-Geva T, Erlichman M, Pollak Y, Gross-Tsur V. Characterization of minipuberty in infants with Prader Willi syndrome. Horm Res Paediatr. 2014;82(230–237):118.
67.
Zurück zum Zitat Eldar-Geva T, Hirsch HJ, Pollak Y, Benarroch F, Gross-Tsur V. Management of hypogonadism in adolescent girls and adult women with Prader-Willi syndrome. Am J Med Genet A. 2013;161A:3030–4.CrossRefPubMed Eldar-Geva T, Hirsch HJ, Pollak Y, Benarroch F, Gross-Tsur V. Management of hypogonadism in adolescent girls and adult women with Prader-Willi syndrome. Am J Med Genet A. 2013;161A:3030–4.CrossRefPubMed
68.
Zurück zum Zitat Akefeldt A, Tornhage CJ, Gillberg C. A woman with Prader-Willi syndrome gives birth to a healthy baby girl. Dev Med Child Neurol. 1999;41(789–790):122. Akefeldt A, Tornhage CJ, Gillberg C. A woman with Prader-Willi syndrome gives birth to a healthy baby girl. Dev Med Child Neurol. 1999;41(789–790):122.
69.
Zurück zum Zitat Schulze A, Mogensen H, Hamborg-Petersen B, Graem N, Ostergaard JR, Brondum-Nielsen K. Fertility in PraderWilli syndrome: a case report with Angelman syndrome in the offspring. Acta Paediatr. 2001;90(455–459):123. Schulze A, Mogensen H, Hamborg-Petersen B, Graem N, Ostergaard JR, Brondum-Nielsen K. Fertility in PraderWilli syndrome: a case report with Angelman syndrome in the offspring. Acta Paediatr. 2001;90(455–459):123.
70.
Zurück zum Zitat Schmidt H, Schwarz PS. Premature adrenarche, increased growth velocity and accelerated bone age in male patients with Prader-Labhart-Willi syndrome. Eur J Pediatr. 2001;160(69–70):124. Schmidt H, Schwarz PS. Premature adrenarche, increased growth velocity and accelerated bone age in male patients with Prader-Labhart-Willi syndrome. Eur J Pediatr. 2001;160(69–70):124.
71.
Zurück zum Zitat Butler MG, Haber L, Mernaugh R, Carlson MG, Price R, Feurer ID. Decreased bone mineral density in PraderWilli syndrome: comparison with obese subjects. Am J Med Genet. 2001;103(216–222):127. Butler MG, Haber L, Mernaugh R, Carlson MG, Price R, Feurer ID. Decreased bone mineral density in PraderWilli syndrome: comparison with obese subjects. Am J Med Genet. 2001;103(216–222):127.
72.
Zurück zum Zitat Vestergaard P, Kristensen K, Bruun JM, Østergaard JR, Heickendorff L, Mosekilde L, et al. Reduced bone mineral density and increased bone turnover in Prader-Willi syndrome compared with controls matched for sex and body mass index—a cross-sectional study. J Pediatr. 2004;144(5):614–9 128.CrossRefPubMed Vestergaard P, Kristensen K, Bruun JM, Østergaard JR, Heickendorff L, Mosekilde L, et al. Reduced bone mineral density and increased bone turnover in Prader-Willi syndrome compared with controls matched for sex and body mass index—a cross-sectional study. J Pediatr. 2004;144(5):614–9 128.CrossRefPubMed
73.
Zurück zum Zitat Young J. Approach to the male patient with congenital hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2012;97:707–18.CrossRefPubMed Young J. Approach to the male patient with congenital hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2012;97:707–18.CrossRefPubMed
74.
Zurück zum Zitat Bridges N. What is the value of growth hormone therapy in Prader Willi syndrome? Arch Dis Child. 2014;99:166–70.CrossRefPubMed Bridges N. What is the value of growth hormone therapy in Prader Willi syndrome? Arch Dis Child. 2014;99:166–70.CrossRefPubMed
75.
Zurück zum Zitat Petriczko E, Horodnicka-Józwa A, Szmit-Domagalska J, et al. Aspekty endokrynne zespołu Pradera i Williego u dzieci i młodzieży. Pediatr Pol. 2008;83(5):522–8.CrossRef Petriczko E, Horodnicka-Józwa A, Szmit-Domagalska J, et al. Aspekty endokrynne zespołu Pradera i Williego u dzieci i młodzieży. Pediatr Pol. 2008;83(5):522–8.CrossRef
76.
Zurück zum Zitat Cohen M, Harrington J, Narang I, Hamilton J. Growth hormone secretion decreases with age in paediatric Prader-Willi syndrome. Clin Endocrinol. 2015;83:212–5.CrossRef Cohen M, Harrington J, Narang I, Hamilton J. Growth hormone secretion decreases with age in paediatric Prader-Willi syndrome. Clin Endocrinol. 2015;83:212–5.CrossRef
77.
Zurück zum Zitat Di Giorgio G, Grugni G, Fintini D, et al. Growth hormone response to standard provocative stimuli and combined tests in very young children with Prader-Willi syndrome. Horm Res Paediatr. 2014;81:189–95.CrossRefPubMed Di Giorgio G, Grugni G, Fintini D, et al. Growth hormone response to standard provocative stimuli and combined tests in very young children with Prader-Willi syndrome. Horm Res Paediatr. 2014;81:189–95.CrossRefPubMed
78.
Zurück zum Zitat Deal CL, Tony M, Hoybye C, et al. Growth hormone in Prader Willi syndrome clinical care guidelines workshop participants. Growth Hormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in PraderWilli syndrome. J Clin Endocrinol Metab 2013. 2013;98:E1072–e87.CrossRef Deal CL, Tony M, Hoybye C, et al. Growth hormone in Prader Willi syndrome clinical care guidelines workshop participants. Growth Hormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in PraderWilli syndrome. J Clin Endocrinol Metab 2013. 2013;98:E1072–e87.CrossRef
79.
Zurück zum Zitat Miller JL, Goldstone AP, Couch JA, Shuster J, He G, Driscoll DJ, et al. Pituitary abnormalities in Prader-Willi syndrome and early onset morbid obesity. Am J Med Genet A. 2008;146A:570–7.CrossRefPubMed Miller JL, Goldstone AP, Couch JA, Shuster J, He G, Driscoll DJ, et al. Pituitary abnormalities in Prader-Willi syndrome and early onset morbid obesity. Am J Med Genet A. 2008;146A:570–7.CrossRefPubMed
80.
Zurück zum Zitat Cassidy SB, Schwartz S, Miller JL, et al. Prader Willi syndrome. Genet Med. 2012;14:10e26.CrossRef Cassidy SB, Schwartz S, Miller JL, et al. Prader Willi syndrome. Genet Med. 2012;14:10e26.CrossRef
81.
Zurück zum Zitat Góralska M, Bednarczuk T, Rosłon M, Libura M, Szalecki M, Hilczer M, et al. Management of Prader-Willi Syndrome (PWS) in adults - what an endocrinologist needs to know. Recommendations of the Polish Society of Endocrinology and the Polish Society of Paediatric Endocrinology and Diabetology. Endokrynol Pol. 2018;69. Góralska M, Bednarczuk T, Rosłon M, Libura M, Szalecki M, Hilczer M, et al. Management of Prader-Willi Syndrome (PWS) in adults - what an endocrinologist needs to know. Recommendations of the Polish Society of Endocrinology and the Polish Society of Paediatric Endocrinology and Diabetology. Endokrynol Pol. 2018;69.
82.
Zurück zum Zitat Grugni G, Marzullo P. Diagnosis and treatment of GH deficiency in Prader-Willi syndrome. Best Pract Res Clin Endocrinol Metab. 2016;30(6):785–94.CrossRefPubMed Grugni G, Marzullo P. Diagnosis and treatment of GH deficiency in Prader-Willi syndrome. Best Pract Res Clin Endocrinol Metab. 2016;30(6):785–94.CrossRefPubMed
83.
Zurück zum Zitat Lafortuna CL, Minocci A, Capodaglio P, et al. Growth hormone therapy improves exercise capacity in adult patients with Prader-Willi syndrome. J Endocrinol Investig. 2008;31(9):765–72.CrossRef Lafortuna CL, Minocci A, Capodaglio P, et al. Growth hormone therapy improves exercise capacity in adult patients with Prader-Willi syndrome. J Endocrinol Investig. 2008;31(9):765–72.CrossRef
84.
Zurück zum Zitat Siemensma EP, de Lind van Wijngaarden RF, Festen DA, et al. Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study. J Clin Endocrinol Metab. 2012;97:2307–14.CrossRefPubMed Siemensma EP, de Lind van Wijngaarden RF, Festen DA, et al. Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study. J Clin Endocrinol Metab. 2012;97:2307–14.CrossRefPubMed
85.
Zurück zum Zitat Höybye C, Thorén M, Böhm B. Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome. J Intellect Disabil Res. 2005;49(Pt 4):245–52.CrossRefPubMed Höybye C, Thorén M, Böhm B. Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome. J Intellect Disabil Res. 2005;49(Pt 4):245–52.CrossRefPubMed
86.
Zurück zum Zitat Sode-Carlsen R, Farholt S, Rabben KF, et al. One year of growth hormone treatment in adults with Prader-Willi syndrome improves body composition: results from a randomized, placebo-controlled study. J Clin Endocrinol Metab. 2010;95(11):4943–50.CrossRefPubMed Sode-Carlsen R, Farholt S, Rabben KF, et al. One year of growth hormone treatment in adults with Prader-Willi syndrome improves body composition: results from a randomized, placebo-controlled study. J Clin Endocrinol Metab. 2010;95(11):4943–50.CrossRefPubMed
87.
Zurück zum Zitat Deal CL, Tony M, Höybye C, Allen DB, Tauber M, Christiansen JS, et al. Growth Hormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab. 2013;98:E1072–87.CrossRefPubMedPubMedCentral Deal CL, Tony M, Höybye C, Allen DB, Tauber M, Christiansen JS, et al. Growth Hormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab. 2013;98:E1072–87.CrossRefPubMedPubMedCentral
88.
Zurück zum Zitat Festen DA, de Lind van Wijngaarden R, van Eekelen M, et al. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome. Clin Endocrinol (Oxf). 2008;69:443–5.CrossRef Festen DA, de Lind van Wijngaarden R, van Eekelen M, et al. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome. Clin Endocrinol (Oxf). 2008;69:443–5.CrossRef
89.
Zurück zum Zitat Bakker NE, Kuppens RJ, Siemensma EP, Wijngaarden RF, Festen DA, Bindels-de Heus GC, et al. Eight years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects. J Clin Endocrinol Metab. 2013;98:4013–22.CrossRefPubMed Bakker NE, Kuppens RJ, Siemensma EP, Wijngaarden RF, Festen DA, Bindels-de Heus GC, et al. Eight years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects. J Clin Endocrinol Metab. 2013;98:4013–22.CrossRefPubMed
90.
Zurück zum Zitat Colmenares A, Pinto G, Taupin P, Giuseppe A, Odent T, Trivin C, et al. Effects on growth and metabolism of growth hormone treatment for 3 years in 36 children with Prader-Willi syndrome. Horm Res Paediatr. 2011;75:123–30.CrossRefPubMed Colmenares A, Pinto G, Taupin P, Giuseppe A, Odent T, Trivin C, et al. Effects on growth and metabolism of growth hormone treatment for 3 years in 36 children with Prader-Willi syndrome. Horm Res Paediatr. 2011;75:123–30.CrossRefPubMed
91.
Zurück zum Zitat Myers SE, Whitman BY, Carrel AL, Moerchen V, Bekx MT, Allen DB. Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits. Am J Med Genet A. 2007;143A:443–8.CrossRefPubMed Myers SE, Whitman BY, Carrel AL, Moerchen V, Bekx MT, Allen DB. Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits. Am J Med Genet A. 2007;143A:443–8.CrossRefPubMed
92.
Zurück zum Zitat Carrel AL, Myers SE, Whitman BY, Allen DB. Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study. J Clin Endocrinol Metab. 2002;87:1581–5.CrossRefPubMed Carrel AL, Myers SE, Whitman BY, Allen DB. Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study. J Clin Endocrinol Metab. 2002;87:1581–5.CrossRefPubMed
93.
Zurück zum Zitat Passone CBG, Pasqualucci PL, Franco RR, Ito SS, Mattar LBF, Koiffmann CP, et al. Prader-Willi syndrome: what is the general pediatrician supposed to do? A review. Rev Paul Pediatr. 2018;36(3):345–52.CrossRefPubMedPubMedCentral Passone CBG, Pasqualucci PL, Franco RR, Ito SS, Mattar LBF, Koiffmann CP, et al. Prader-Willi syndrome: what is the general pediatrician supposed to do? A review. Rev Paul Pediatr. 2018;36(3):345–52.CrossRefPubMedPubMedCentral
94.
Zurück zum Zitat Van Vliet G, Deal CL, Crock PA, et al. Sudden death in growth hormone-treated children with Prader-Willi syndrome. J Pediatr. 2004;144:129–31.CrossRefPubMed Van Vliet G, Deal CL, Crock PA, et al. Sudden death in growth hormone-treated children with Prader-Willi syndrome. J Pediatr. 2004;144:129–31.CrossRefPubMed
Metadaten
Titel
Prader- Willi syndrome: An uptodate on endocrine and metabolic complications
verfasst von
Giovanna Muscogiuri
Gloria Formoso
Gabriella Pugliese
Rosaria Maddalena Ruggeri
Elisabetta Scarano
Annamaria Colao
on behalf of RESTARE
Publikationsdatum
07.05.2019
Verlag
Springer US
Erschienen in
Reviews in Endocrine and Metabolic Disorders / Ausgabe 2/2019
Print ISSN: 1389-9155
Elektronische ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-019-09502-2

Weitere Artikel der Ausgabe 2/2019

Reviews in Endocrine and Metabolic Disorders 2/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.